Back to search
FDAFDA · Food and drugs·Recall number D-0524-2026

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

Published May 13, 2026 · Recall initiated: December 27, 2025

Summary

FDA records drug Class II recall D-0524-2026, published May 13, 2026 and initiated December 27, 2025. Recalling firm: Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles; Status: Ongoing; Reported quantity: 1 bag; Lot: Lot #: 11-4909703-0-1, Exp 12/28/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect Product Formulation: product did not contain insulin as listed in the label.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
Distributor
CA
Lot
Lot #: 11-4909703-0-1, Exp 12/28/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670 recalled?

Yes. FDA published recall D-0524-2026 on May 13, 2026. Reported hazard: Incorrect Product Formulation: product did not contain insulin as listed in the label.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone